{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T20:39:44Z","timestamp":1722631184857},"reference-count":36,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2017.5219","type":"journal-article","created":{"date-parts":[[2017,9,29]],"date-time":"2017-09-29T08:01:57Z","timestamp":1506672117000},"source":"Crossref","is-referenced-by-count":4,"title":["Predictors for advanced liver fibrosis in chronic hepatitis B virus infection with persistently normal or mildly elevated alanine aminotransferase"],"prefix":"10.3892","author":[{"given":"Dexin","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Medicine, The Sixth People's Hospital of Qingdao, Qingdao, Shandong 266033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Sixth People's Hospital of Qingdao, Qingdao, Shandong 266033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medicine, The Sixth People's Hospital of Qingdao, Qingdao, Shandong 266033, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,29]]},"reference":[{"key":"key20200713142730_b1-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1016\/j.vaccine.2005.11.035","article-title":"Progress in the control of hepatitis B infection in the Western Pacific Region","volume":"24","author":"Clements","year":"2006","journal-title":"Vaccine"},{"key":"key20200713142730_b2-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jhep.2009.04.003","article-title":"Antiviral therapy of chronic hepatitis B: Opportunities and challenges in Asia","volume":"51","author":"Liaw","year":"2009","journal-title":"J Hepatol"},{"key":"key20200713142730_b3-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: New estimates of age-specific HBsAg seroprevalence and endemicity","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"key20200713142730_b4-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s12072-012-9365-4","article-title":"Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update","volume":"6","author":"Liaw","year":"2012","journal-title":"Hepatol Int"},{"key":"key20200713142730_b5-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: A 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"key20200713142730_b6-etm-0-0-5219","first-page":"649","article-title":"Chronic hepatitis B in children - a review","volume":"24","author":"Rukunuzzaman","year":"2015","journal-title":"Mymensingh Med J"},{"key":"key20200713142730_b7-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","article-title":"Liver biopsy","volume":"344","author":"Bravo","year":"2001","journal-title":"N Engl J Med"},{"key":"key20200713142730_b8-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3109\/00365513.2015.1125013","article-title":"Aspartate aminotransferase to platelet ratio index-a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues","volume":"76","author":"Peng","year":"2016","journal-title":"Scand J Clin Lab Invest"},{"key":"key20200713142730_b9-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"261","DOI":"10.7863\/ultra.15.12054","article-title":"Dynamic changes in liver stiffness measured by transient elastography predict clinical outcomes among patients with chronic hepatitis B","volume":"36","author":"Zeng","year":"2017","journal-title":"J Ultrasound Med"},{"key":"key20200713142730_b10-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"e7021","DOI":"10.1097\/MD.0000000000007021","article-title":"Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine","volume":"96","author":"Cai","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"key20200713142730_b11-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.jhep.2012.04.004","article-title":"European Association for the Study of Liver: EASL clinical practical guidelines: Management of alcoholic liver disease","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"key20200713142730_b12-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1471-2334-14-85","article-title":"Dynamic comparison between Daan real-time PCR and Cobas TaqMan for quantification of HBV DNA levels in patients with CHB","volume":"14","author":"Cai","year":"2014","journal-title":"BMC Infect Dis"},{"key":"key20200713142730_b13-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/j.1365-2893.2009.01087.x","article-title":"Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis","volume":"16","author":"Castera","year":"2009","journal-title":"J Viral Hepat"},{"key":"key20200713142730_b14-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1046\/j.1365-2893.1997.00141.x","article-title":"Age and platelet count: A simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups","volume":"4","author":"Poynard","year":"1997","journal-title":"J Viral Hepat"},{"key":"key20200713142730_b15-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: A new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"key20200713142730_b16-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10238-015-0373-2","article-title":"Comparison of entecavir monotherapy and de novo lamivudine and adefovir combination therapy in HBeAg-positive chronic hepatitis B with high viral load: 48-week result","volume":"16","author":"Cai","year":"2016","journal-title":"Clin Exp Med"},{"key":"key20200713142730_b17-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.cgh.2016.12.012","article-title":"Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients","volume":"15","author":"Sharaiha","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20200713142730_b18-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1756283X16681707","article-title":"A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B","volume":"10","author":"Ou","year":"2017","journal-title":"Therap Adv Gastroenterol"},{"key":"key20200713142730_b19-etm-0-0-5219","first-page":"385","article-title":"IL-17 expression is correlated with hepatitis B-related liver diseases and fibrosis","volume":"27","author":"Wang","year":"2011","journal-title":"Int J Mol Med"},{"key":"key20200713142730_b20-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3892\/ijmm.2012.1148","article-title":"HBV promotes the proliferation of hepatic stellate cells via the PDGF-B\/PDGFR-\u03b2 signaling pathway in vitro","volume":"30","author":"Bai","year":"2012","journal-title":"Int J Mol Med"},{"key":"key20200713142730_b21-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3892\/ijmm.2015.2264","article-title":"Identification of novel targets for the diagnosis and treatment of liver fibrosis","volume":"36","author":"Fagone","year":"2015","journal-title":"Int J Mol Med"},{"key":"key20200713142730_b22-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.drudis.2015.10.015","article-title":"Emerging therapeutic targets for the treatment of hepatic fibrosis","volume":"21","author":"Fagone","year":"2016","journal-title":"Drug Discov Today"},{"key":"key20200713142730_b23-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.3892\/mmr.2015.4221","article-title":"Analysis of the differential expression of circulating microRNAs during the progression of hepatic fibrosis in patients with chronic hepatitis B virus infection","volume":"12","author":"Zhang","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713142730_b24-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3389\/fphar.2017.00056","article-title":"Circulating ECV-associated miRNAs as potential clinical biomarkers in early stage HBV and HCV induced liver fibrosis","volume":"8","author":"Lambrecht","year":"2017","journal-title":"Front Pharmacol"},{"key":"key20200713142730_b25-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.3892\/mmr.2015.3546","article-title":"Serum microRNA-125a-5p, a useful biomarker in liver diseases, correlates with disease progression","volume":"12","author":"Zheng","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20200713142730_b26-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1136\/gut.2005.065136","article-title":"Prognostic determinants for chronic hepatitis B in Asians: Therapeutic implications","volume":"54","author":"Yuen","year":"2005","journal-title":"Gut"},{"key":"key20200713142730_b27-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1053\/j.gastro.2008.02.075","article-title":"Virologic and histologic features of chronic hepatitis B virus-infected asymptomatic patients with persistently normal ALT","volume":"134","author":"Kumar","year":"2008","journal-title":"Gastroenterology"},{"key":"key20200713142730_b28-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/hep.28156","article-title":"American Association for the Study of Liver Diseases: AASLD guidelines for treatment of chronic hepatitis B","volume":"63","author":"Terrault","year":"2016","journal-title":"Hepatology"},{"key":"key20200713142730_b29-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"9343960","DOI":"10.1155\/2016\/9343960","article-title":"Comment on \u2018assessment of liver stiffness in pediatric fontan patients using transient elastography\u2019","volume":"2016","author":"Xue","year":"2016","journal-title":"Can J Gastroenterol Hepatol"},{"key":"key20200713142730_b30-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1002\/hep.22878","article-title":"Long-term outcome of hepatitis B e antigen-negative hepatitis B surface antigen carriers in relation to changes of alanine aminotransferase levels over time","volume":"49","author":"Tai","year":"2009","journal-title":"Hepatology"},{"key":"key20200713142730_b31-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"key20200713142730_b32-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1002\/hep.21585","article-title":"Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels","volume":"45","author":"Lin","year":"2007","journal-title":"Hepatology"},{"key":"key20200713142730_b33-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1111\/j.1440-1746.2011.06736.x","article-title":"Transient elastographic evaluation in adult subjects without overt liver disease: Influence of alanine aminotransferase levels","volume":"26","author":"Kumar","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200713142730_b34-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1002\/hep.510290307","article-title":"Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats","volume":"29","author":"Yasuda","year":"1999","journal-title":"Hepatology"},{"key":"key20200713142730_b35-etm-0-0-5219","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/gutjnl-2016-311554","article-title":"Diagnostic accuracy of the gamma-glutamyl transpeptidase to platelet ratio (GPR) using transient elastography as a reference","volume":"66","author":"Lemoine","year":"2017","journal-title":"Gut"},{"key":"key20200713142730_b36-etm-0-0-5219","first-page":"19","article-title":"The independent predictors of significant liver histological changes in chronic hepatitis B virus infection patients with persistently high-normal or low-normal alanine transaminase levels","volume":"23","author":"Li","year":"2017","journal-title":"Discov Med"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T13:30:27Z","timestamp":1594647027000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5219"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,29]]},"references-count":36,"URL":"https:\/\/doi.org\/10.3892\/etm.2017.5219","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,29]]}}}